Lukić, Jelena

Link to this page

Authority KeyName Variants
454457ec-53da-4c98-a81c-867354891559
  • Lukić, Jelena (4)
Projects

Author's Bibliography

Deep Eutectic Solvent Based Reversed-Phase Dispersive Liquid–Liquid Microextraction and High-Performance Liquid Chromatography for the Determination of Free Tryptophan in Cold-Pressed Oils

Ražić, Slavica; Bakić, Tamara; Topić, Aleksandra; Lukić, Jelena; Onjia, Antonije

(MDPI, 2023)

TY  - JOUR
AU  - Ražić, Slavica
AU  - Bakić, Tamara
AU  - Topić, Aleksandra
AU  - Lukić, Jelena
AU  - Onjia, Antonije
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4549
AB  - A fast and straightforward reversed-phase dispersive liquid–liquid microextraction (RP-DLLME) using a deep eutectic solvent (DES) procedure to determine free tryptophan in vegetable oils was developed. The influence of eight variables affecting the RP-DLLME efficiency has been studied by a multivariate approach. A Plackett–Burman design for screening the most influential variables followed by a central composite response surface methodology led to an optimum RP-DLLME setup for a 1 g oil sample: 9 mL hexane as the diluting solvent, vortex extraction with 0.45 mL of DES (choline chloride–urea) at 40 °C, without addition of salt, and centrifugation at 6000 rpm for 4.0 min. The reconstituted extract was directly injected into a high-performance liquid chromatography (HPLC) system working in the diode array mode. At the studied concentration levels, the obtained method detection limits (MDL) was 11 mg/kg, linearity in matrix-matched standards was R2 ≥ 0.997, relative standard deviations (RSD) was 7.8%, and average recovery was 93%. The combined use of the recently developed DES -based RP-DLLME and HPLC provides an innovative, efficient, cost-effective, and more sustainable method for the extraction and quantification of free tryptophan in oily food matrices. The method was employed to analyze cold-pressed oils from nine vegetables (Brazil nut, almond, cashew, hazelnut, peanut, pumpkin, sesame, sunflower, and walnut) for the first time. The results showed that free tryptophan was present in the range of 11–38 mg/100 g. This article is important for its contributions to the field of food analysis, and for its development of a new and efficient method for the determination of free tryptophan in complex matrices, which has the potential to be applied to other analytes and sample types.
PB  - MDPI
T2  - Molecules
T1  - Deep Eutectic Solvent Based Reversed-Phase Dispersive Liquid–Liquid Microextraction and High-Performance Liquid Chromatography for the Determination of Free Tryptophan in Cold-Pressed Oils
VL  - 28
IS  - 5
DO  - 10.3390/molecules28052395
ER  - 
@article{
author = "Ražić, Slavica and Bakić, Tamara and Topić, Aleksandra and Lukić, Jelena and Onjia, Antonije",
year = "2023",
abstract = "A fast and straightforward reversed-phase dispersive liquid–liquid microextraction (RP-DLLME) using a deep eutectic solvent (DES) procedure to determine free tryptophan in vegetable oils was developed. The influence of eight variables affecting the RP-DLLME efficiency has been studied by a multivariate approach. A Plackett–Burman design for screening the most influential variables followed by a central composite response surface methodology led to an optimum RP-DLLME setup for a 1 g oil sample: 9 mL hexane as the diluting solvent, vortex extraction with 0.45 mL of DES (choline chloride–urea) at 40 °C, without addition of salt, and centrifugation at 6000 rpm for 4.0 min. The reconstituted extract was directly injected into a high-performance liquid chromatography (HPLC) system working in the diode array mode. At the studied concentration levels, the obtained method detection limits (MDL) was 11 mg/kg, linearity in matrix-matched standards was R2 ≥ 0.997, relative standard deviations (RSD) was 7.8%, and average recovery was 93%. The combined use of the recently developed DES -based RP-DLLME and HPLC provides an innovative, efficient, cost-effective, and more sustainable method for the extraction and quantification of free tryptophan in oily food matrices. The method was employed to analyze cold-pressed oils from nine vegetables (Brazil nut, almond, cashew, hazelnut, peanut, pumpkin, sesame, sunflower, and walnut) for the first time. The results showed that free tryptophan was present in the range of 11–38 mg/100 g. This article is important for its contributions to the field of food analysis, and for its development of a new and efficient method for the determination of free tryptophan in complex matrices, which has the potential to be applied to other analytes and sample types.",
publisher = "MDPI",
journal = "Molecules",
title = "Deep Eutectic Solvent Based Reversed-Phase Dispersive Liquid–Liquid Microextraction and High-Performance Liquid Chromatography for the Determination of Free Tryptophan in Cold-Pressed Oils",
volume = "28",
number = "5",
doi = "10.3390/molecules28052395"
}
Ražić, S., Bakić, T., Topić, A., Lukić, J.,& Onjia, A.. (2023). Deep Eutectic Solvent Based Reversed-Phase Dispersive Liquid–Liquid Microextraction and High-Performance Liquid Chromatography for the Determination of Free Tryptophan in Cold-Pressed Oils. in Molecules
MDPI., 28(5).
https://doi.org/10.3390/molecules28052395
Ražić S, Bakić T, Topić A, Lukić J, Onjia A. Deep Eutectic Solvent Based Reversed-Phase Dispersive Liquid–Liquid Microextraction and High-Performance Liquid Chromatography for the Determination of Free Tryptophan in Cold-Pressed Oils. in Molecules. 2023;28(5).
doi:10.3390/molecules28052395 .
Ražić, Slavica, Bakić, Tamara, Topić, Aleksandra, Lukić, Jelena, Onjia, Antonije, "Deep Eutectic Solvent Based Reversed-Phase Dispersive Liquid–Liquid Microextraction and High-Performance Liquid Chromatography for the Determination of Free Tryptophan in Cold-Pressed Oils" in Molecules, 28, no. 5 (2023),
https://doi.org/10.3390/molecules28052395 . .
1
3
2

Процена безбедносног профила лекова примењених у периоду дојења применом базе података e-lactancia

Lukić, Katarina; Lukić, Jelena

(2023)

TY  - CONF
AU  - Lukić, Katarina
AU  - Lukić, Jelena
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4796
AB  - Увод: Дојење представља физиолошки процес са позитивним аспектом како на мајку, тако и на дете. Дојиље се свакодневно сусрећу са различитим проблемима током дојења, који често резултују престанком истог. Употреба лекова током овог периода представља изазов, како за дојиљу, тако и за здравствене раднике, због могућности проласка лека у млеко. Како би се здравственим радницима олакшало долажење до тачних и прецизних информација на брз начин, основана је база e-lactancia.
Циљ рада: Анализа терапије примењене у периоду дојења и безбедност исте по одoјче.
Материјал и методе: У овом раду су представљени резултати статистичке анализе података истраживања у оквиру пројекта „Mama Friendly Апотека – за безбедну примену лекова у току дојења – Ваш фармацеут“.
Резултати: Истраживање показује да је од 114 испитаница, њих 106 примењивало лекове и/или дијететске суплементе, односно да је било примењено 49 различитих лекова и 21 дијететски суплемент. Од тога је 86,64% коришћених лекова/дијететских суплемената означено веома ниским ризиком, 18,46% су препарати означени ниским ризиком, а за 6,14% није било података у бази. Најчешћа индикација за примену лекова су била различита болна стања, инфекције, алергије и друга обољења. Најчешће коришћени лекови су ибупрофен, деслоратадин, амоксицилин, ацетилцистеин и диклофенак.
Закључак: За крај, дата је препорука за побољшање базе и побројани су фактори са највећим утицајем на прелазак лека у млеко.
AB  - Introduction: Breastfeeding is a physiological process with a positive aspect for both mother and child. Breastfeeding women encounter various issues during breastfeeding every day, which often result in early cessation of breastfeeding. The use of drugs during this period is a challenge, both for the nursing mother and for health workers, due to the possibility of entering a drug into the milk.  In order to facilitate health workers  the access to accurate and precise information about compatibility drugs and breastfeedeing process, the E-lactancia database was created.
The Aim: To analyze therapy applied during breastfeeding and safety of the therapy for an infant.
Material and Methods: This paper presents the results of the statistical analysis of research data within the project "Mama Friendly Pharmacy - for the safe use of medicines during breastfeeding - Your pharmacist".
Results: The research show that out of 114 respondents, 106 of them used drugs and/or dietary supplements, that is, 49 different drugs and 21 dietary supplements were used. 86.64% of the used drugs/dietary supplements were marked as very low risk, 18.46% were preparations marked as low risk, and for 6.14% there was no data in the database. The most common indication for the use of drugs was various painful conditions, infections, allergies, and other diseases. The most commonly used drugs are ibuprofen, desloratadine, amoxicillin, acetylcysteine and diclofenac.
Conclusion: Finally, a recommendation for improving the base is given and the factors with the greatest influence on the transfer of the drug into milk are listed.
T1  - Процена безбедносног профила лекова примењених у периоду дојења применом базе података e-lactancia
T1  - Evaluation of the safety profile of drugs consumed during breastfeeding period using the e-lactancia database
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4796
ER  - 
@conference{
author = "Lukić, Katarina and Lukić, Jelena",
year = "2023",
abstract = "Увод: Дојење представља физиолошки процес са позитивним аспектом како на мајку, тако и на дете. Дојиље се свакодневно сусрећу са различитим проблемима током дојења, који често резултују престанком истог. Употреба лекова током овог периода представља изазов, како за дојиљу, тако и за здравствене раднике, због могућности проласка лека у млеко. Како би се здравственим радницима олакшало долажење до тачних и прецизних информација на брз начин, основана је база e-lactancia.
Циљ рада: Анализа терапије примењене у периоду дојења и безбедност исте по одoјче.
Материјал и методе: У овом раду су представљени резултати статистичке анализе података истраживања у оквиру пројекта „Mama Friendly Апотека – за безбедну примену лекова у току дојења – Ваш фармацеут“.
Резултати: Истраживање показује да је од 114 испитаница, њих 106 примењивало лекове и/или дијететске суплементе, односно да је било примењено 49 различитих лекова и 21 дијететски суплемент. Од тога је 86,64% коришћених лекова/дијететских суплемената означено веома ниским ризиком, 18,46% су препарати означени ниским ризиком, а за 6,14% није било података у бази. Најчешћа индикација за примену лекова су била различита болна стања, инфекције, алергије и друга обољења. Најчешће коришћени лекови су ибупрофен, деслоратадин, амоксицилин, ацетилцистеин и диклофенак.
Закључак: За крај, дата је препорука за побољшање базе и побројани су фактори са највећим утицајем на прелазак лека у млеко., Introduction: Breastfeeding is a physiological process with a positive aspect for both mother and child. Breastfeeding women encounter various issues during breastfeeding every day, which often result in early cessation of breastfeeding. The use of drugs during this period is a challenge, both for the nursing mother and for health workers, due to the possibility of entering a drug into the milk.  In order to facilitate health workers  the access to accurate and precise information about compatibility drugs and breastfeedeing process, the E-lactancia database was created.
The Aim: To analyze therapy applied during breastfeeding and safety of the therapy for an infant.
Material and Methods: This paper presents the results of the statistical analysis of research data within the project "Mama Friendly Pharmacy - for the safe use of medicines during breastfeeding - Your pharmacist".
Results: The research show that out of 114 respondents, 106 of them used drugs and/or dietary supplements, that is, 49 different drugs and 21 dietary supplements were used. 86.64% of the used drugs/dietary supplements were marked as very low risk, 18.46% were preparations marked as low risk, and for 6.14% there was no data in the database. The most common indication for the use of drugs was various painful conditions, infections, allergies, and other diseases. The most commonly used drugs are ibuprofen, desloratadine, amoxicillin, acetylcysteine and diclofenac.
Conclusion: Finally, a recommendation for improving the base is given and the factors with the greatest influence on the transfer of the drug into milk are listed.",
title = "Процена безбедносног профила лекова примењених у периоду дојења применом базе података e-lactancia, Evaluation of the safety profile of drugs consumed during breastfeeding period using the e-lactancia database",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4796"
}
Lukić, K.,& Lukić, J.. (2023). Процена безбедносног профила лекова примењених у периоду дојења применом базе података e-lactancia. .
https://hdl.handle.net/21.15107/rcub_farfar_4796
Lukić K, Lukić J. Процена безбедносног профила лекова примењених у периоду дојења применом базе података e-lactancia. 2023;.
https://hdl.handle.net/21.15107/rcub_farfar_4796 .
Lukić, Katarina, Lukić, Jelena, "Процена безбедносног профила лекова примењених у периоду дојења применом базе података e-lactancia" (2023),
https://hdl.handle.net/21.15107/rcub_farfar_4796 .

Association between Val158Met COMT, TNF-alpha-857 C > T, TNFR1 36 A > G, IL-1 alpha 4845 G > T and IL-10-1082 A > G Polymorphisms and Risk of Early-Onset Preeclampsia and Its Complications

Krnjeta, Tijana; Mirković, Ljiljana; Ignjatović, Svetlana; Tomasević, Dragana; Lukić, Jelena; Topalov, Drina; Majkić-Singh, Nada

(Vojnomedicinska akademija - Institut za naučne informacije, Beograd, 2017)

TY  - JOUR
AU  - Krnjeta, Tijana
AU  - Mirković, Ljiljana
AU  - Ignjatović, Svetlana
AU  - Tomasević, Dragana
AU  - Lukić, Jelena
AU  - Topalov, Drina
AU  - Majkić-Singh, Nada
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2848
AB  - Background/Aim. Preeclampsia (PE) belongs to the group of hypertensive disorders in pregnancy with the global average incidence of 2.16%. It is considered as one of the leading causes of maternal and neonatal morbidity and mortality worldwide. The goal of this study was to assess the potential association between Val158Met catechol-o-methyltransferase (COMT), tumor necrosis factor-alpha (TNF-alpha) -857 C>T, tumor necrosis factor receptor 1 (TNFR1) 36 A>G, interleukin-1alpha (IL-1 alpha) 4845 G>T and interleukin-10 (IL-10) -1082 A>G polymorphisms and risk of early-onset preeclampsia (PE) and its complications. Methods. The study included 47 early-onset PE patients, which were grouped by disease severity and by size for gestational age and 47 control cases. The Val158Met polymorphism was genotyped by polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) analysis and inflammatory cytokine polymorphisms by the Sanger sequencing method. Results. The COMT Met allele as well as IL-1 alpha T showed a protective role, decreasing the risk of early-onset PE after age and body mass index (BMI) adjustments. The detected interactions between the COMT Met and IL-10 A alleles, as well as between the COMT Met and TNF-alpha T alleles were insignificant after age and BMI adjustments. Conclusion. COMT and IL-1 alpha may be used as candidate genes for early-onset PE and its severe form and small for gestational age (SGA) complications.
PB  - Vojnomedicinska akademija - Institut za naučne informacije, Beograd
T2  - Vojnosanitetski pregled
T1  - Association between Val158Met COMT, TNF-alpha-857 C > T, TNFR1 36 A > G, IL-1 alpha 4845 G > T and IL-10-1082 A > G Polymorphisms and Risk of Early-Onset Preeclampsia and Its Complications
VL  - 74
IS  - 12
SP  - 1155
EP  - 1161
DO  - 10.2298/VSP160329313K
ER  - 
@article{
author = "Krnjeta, Tijana and Mirković, Ljiljana and Ignjatović, Svetlana and Tomasević, Dragana and Lukić, Jelena and Topalov, Drina and Majkić-Singh, Nada",
year = "2017",
abstract = "Background/Aim. Preeclampsia (PE) belongs to the group of hypertensive disorders in pregnancy with the global average incidence of 2.16%. It is considered as one of the leading causes of maternal and neonatal morbidity and mortality worldwide. The goal of this study was to assess the potential association between Val158Met catechol-o-methyltransferase (COMT), tumor necrosis factor-alpha (TNF-alpha) -857 C>T, tumor necrosis factor receptor 1 (TNFR1) 36 A>G, interleukin-1alpha (IL-1 alpha) 4845 G>T and interleukin-10 (IL-10) -1082 A>G polymorphisms and risk of early-onset preeclampsia (PE) and its complications. Methods. The study included 47 early-onset PE patients, which were grouped by disease severity and by size for gestational age and 47 control cases. The Val158Met polymorphism was genotyped by polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) analysis and inflammatory cytokine polymorphisms by the Sanger sequencing method. Results. The COMT Met allele as well as IL-1 alpha T showed a protective role, decreasing the risk of early-onset PE after age and body mass index (BMI) adjustments. The detected interactions between the COMT Met and IL-10 A alleles, as well as between the COMT Met and TNF-alpha T alleles were insignificant after age and BMI adjustments. Conclusion. COMT and IL-1 alpha may be used as candidate genes for early-onset PE and its severe form and small for gestational age (SGA) complications.",
publisher = "Vojnomedicinska akademija - Institut za naučne informacije, Beograd",
journal = "Vojnosanitetski pregled",
title = "Association between Val158Met COMT, TNF-alpha-857 C > T, TNFR1 36 A > G, IL-1 alpha 4845 G > T and IL-10-1082 A > G Polymorphisms and Risk of Early-Onset Preeclampsia and Its Complications",
volume = "74",
number = "12",
pages = "1155-1161",
doi = "10.2298/VSP160329313K"
}
Krnjeta, T., Mirković, L., Ignjatović, S., Tomasević, D., Lukić, J., Topalov, D.,& Majkić-Singh, N.. (2017). Association between Val158Met COMT, TNF-alpha-857 C > T, TNFR1 36 A > G, IL-1 alpha 4845 G > T and IL-10-1082 A > G Polymorphisms and Risk of Early-Onset Preeclampsia and Its Complications. in Vojnosanitetski pregled
Vojnomedicinska akademija - Institut za naučne informacije, Beograd., 74(12), 1155-1161.
https://doi.org/10.2298/VSP160329313K
Krnjeta T, Mirković L, Ignjatović S, Tomasević D, Lukić J, Topalov D, Majkić-Singh N. Association between Val158Met COMT, TNF-alpha-857 C > T, TNFR1 36 A > G, IL-1 alpha 4845 G > T and IL-10-1082 A > G Polymorphisms and Risk of Early-Onset Preeclampsia and Its Complications. in Vojnosanitetski pregled. 2017;74(12):1155-1161.
doi:10.2298/VSP160329313K .
Krnjeta, Tijana, Mirković, Ljiljana, Ignjatović, Svetlana, Tomasević, Dragana, Lukić, Jelena, Topalov, Drina, Majkić-Singh, Nada, "Association between Val158Met COMT, TNF-alpha-857 C > T, TNFR1 36 A > G, IL-1 alpha 4845 G > T and IL-10-1082 A > G Polymorphisms and Risk of Early-Onset Preeclampsia and Its Complications" in Vojnosanitetski pregled, 74, no. 12 (2017):1155-1161,
https://doi.org/10.2298/VSP160329313K . .

Protective role of maternal P.VAL158MET catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications

Krnjeta, Tijana; Mirković, Ljiljana; Ignjatović, Svetlana; Tomasević, Dragana; Lukić, Jelena; Topalov, Drina; Soldatović, Ivan; Majkić-Singh, Nada

(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2016)

TY  - JOUR
AU  - Krnjeta, Tijana
AU  - Mirković, Ljiljana
AU  - Ignjatović, Svetlana
AU  - Tomasević, Dragana
AU  - Lukić, Jelena
AU  - Topalov, Drina
AU  - Soldatović, Ivan
AU  - Majkić-Singh, Nada
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2638
AB  - Background: Up until now there have been contradictory data about the association between p.Val158Met catechol-O-methyltransferase (COMT) polymorphism and risk of preeclampsia (PE). The goal of this study was to assess the potential correlation between p.Val158Met COMT polymorphism and risk of early-onset PE, risk of a severe form of early-onset PE, as well as risk of small-for-gestationalage (SGA) complicating PE. Methods: The study included 47 early-onset PE patients and 47 control cases. Forty-seven early-onset PE patients were grouped by disease severity (33 patients with a severe form and 14 patients without severe features) and secondly by size for gestational age (12 patients with appropriate-for-gestational-age (AGA) and 35 patients with SGA size). p.Val158Met polymorphism was genotyped by PCR-RFLP analysis. Results: Allele analysis showed significant difference in COMT allele distribution between early-onset PE and control group as well as early-onset PE SGA and controls (p=0.04057 and p=0.0411 respectively). A statistically significant distribution difference between the severe form and form without severe features of early-onset PE patients was not observed (p>0.05). The highest difference ob served was in the allele recessive model where COMT MetMet genotype was associated with decreased risk of early-onset PE (OR=0.281; 95% CI=0.092-0.7836) and PE complications including severe early-onset PE (OR=0.304; 95% CI=0.086-0.944) and SGA early-onset PE (OR=0.284; 95% CI=0.081-0.874). Conclusions: COMT may be used as a candidate gene for early-onset PE and its severe form and SGA complications.
PB  - Društvo medicinskih biohemičara Srbije, Beograd i Versita
T2  - Journal of Medical Biochemistry
T1  - Protective role of maternal P.VAL158MET catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications
VL  - 35
IS  - 3
SP  - 312
EP  - 318
DO  - 10.1515/jomb-2016-0013
ER  - 
@article{
author = "Krnjeta, Tijana and Mirković, Ljiljana and Ignjatović, Svetlana and Tomasević, Dragana and Lukić, Jelena and Topalov, Drina and Soldatović, Ivan and Majkić-Singh, Nada",
year = "2016",
abstract = "Background: Up until now there have been contradictory data about the association between p.Val158Met catechol-O-methyltransferase (COMT) polymorphism and risk of preeclampsia (PE). The goal of this study was to assess the potential correlation between p.Val158Met COMT polymorphism and risk of early-onset PE, risk of a severe form of early-onset PE, as well as risk of small-for-gestationalage (SGA) complicating PE. Methods: The study included 47 early-onset PE patients and 47 control cases. Forty-seven early-onset PE patients were grouped by disease severity (33 patients with a severe form and 14 patients without severe features) and secondly by size for gestational age (12 patients with appropriate-for-gestational-age (AGA) and 35 patients with SGA size). p.Val158Met polymorphism was genotyped by PCR-RFLP analysis. Results: Allele analysis showed significant difference in COMT allele distribution between early-onset PE and control group as well as early-onset PE SGA and controls (p=0.04057 and p=0.0411 respectively). A statistically significant distribution difference between the severe form and form without severe features of early-onset PE patients was not observed (p>0.05). The highest difference ob served was in the allele recessive model where COMT MetMet genotype was associated with decreased risk of early-onset PE (OR=0.281; 95% CI=0.092-0.7836) and PE complications including severe early-onset PE (OR=0.304; 95% CI=0.086-0.944) and SGA early-onset PE (OR=0.284; 95% CI=0.081-0.874). Conclusions: COMT may be used as a candidate gene for early-onset PE and its severe form and SGA complications.",
publisher = "Društvo medicinskih biohemičara Srbije, Beograd i Versita",
journal = "Journal of Medical Biochemistry",
title = "Protective role of maternal P.VAL158MET catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications",
volume = "35",
number = "3",
pages = "312-318",
doi = "10.1515/jomb-2016-0013"
}
Krnjeta, T., Mirković, L., Ignjatović, S., Tomasević, D., Lukić, J., Topalov, D., Soldatović, I.,& Majkić-Singh, N.. (2016). Protective role of maternal P.VAL158MET catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications. in Journal of Medical Biochemistry
Društvo medicinskih biohemičara Srbije, Beograd i Versita., 35(3), 312-318.
https://doi.org/10.1515/jomb-2016-0013
Krnjeta T, Mirković L, Ignjatović S, Tomasević D, Lukić J, Topalov D, Soldatović I, Majkić-Singh N. Protective role of maternal P.VAL158MET catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications. in Journal of Medical Biochemistry. 2016;35(3):312-318.
doi:10.1515/jomb-2016-0013 .
Krnjeta, Tijana, Mirković, Ljiljana, Ignjatović, Svetlana, Tomasević, Dragana, Lukić, Jelena, Topalov, Drina, Soldatović, Ivan, Majkić-Singh, Nada, "Protective role of maternal P.VAL158MET catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications" in Journal of Medical Biochemistry, 35, no. 3 (2016):312-318,
https://doi.org/10.1515/jomb-2016-0013 . .
4
5
6